News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PolyTherics Acquires Warwick Effect Polymers and Expands Technology Portfolio to Enable the Development of Better Biopharmaceuticals


1/20/2012 6:42:19 AM

LONDON--(BUSINESS WIRE)--PolyTherics Limited (“PolyTherics”), a provider of solutions to biopharmaceutical companies for the improvement of protein and peptide based drugs, is pleased to announce the acquisition of Warwick Effect Polymers (“WEP”), a provider of specialty biopolymers for the modification of biological products.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES